- Joined
- Jul 6, 2006
- Messages
- 576
- Reaction score
- 443
The NEJM study referenced above, after a more thorough consideration, is nonsense. They are presenting the case, through a study subjected to a lot of different types of bias, that SC lines are "safer" than IJ and Fem lines, which is not the case, even based on their data.
They define their "primary outcome event" as a CLABSI or DVT to which they state occurred in 8 SC lines, 20 IJ lines, and 22 femoral lines. Based on this statement alone you may agree that the subclavian seems to be the safest choice. This is a convenient selection of primary outcome event, but what I am most concerned about placing these lines are non compressible arterial punctures and pneumothoraces, which are clearly as dangerous if not moreso on an occurrence basis than a CLABSI or DVT.
They do mention pneumothorax incidences of 13 in SC lines, 4 IJ, and 0 femoral. The authors view this as little more than a foot note, when to me, this is relevant. The combined event rate including pneumothorax is 21 subclavian, 24 IJ, and 22 femoral. A complete non-difference between the three. Further, if you include the number of arterial punctures or placement, subclavians become even less safe, being that it is the one non-compressible site.
In addition, the failure rate for placement of a subclavian in this study is 15%, as compared to 8% and 5% IJ and femoral. Not to mention, in 540 patients the clinicians deemed the subclavian too risky, probably "randomizing" (i.e.: selecting) the highest risk patients to receive IJ and femoral lines. Finally, this study did not mandate real-time ultrasound for IJ placement nor use of chlorhexidine cleansing and dressings for central lines, both widely accepted as standard-of-care today.
This is simply an instance of a study that despite a heavily biased design intended to demonstrate subclavian superiority, is not supported by the data. This is also in the context of the the 2012 meta-analysis of all studies previously done, including two such randomized trials and over 20,000 catheters, which shows no difference in infection rates. http://www.ncbi.nlm.nih.gov/pubmed/22809915
They define their "primary outcome event" as a CLABSI or DVT to which they state occurred in 8 SC lines, 20 IJ lines, and 22 femoral lines. Based on this statement alone you may agree that the subclavian seems to be the safest choice. This is a convenient selection of primary outcome event, but what I am most concerned about placing these lines are non compressible arterial punctures and pneumothoraces, which are clearly as dangerous if not moreso on an occurrence basis than a CLABSI or DVT.
They do mention pneumothorax incidences of 13 in SC lines, 4 IJ, and 0 femoral. The authors view this as little more than a foot note, when to me, this is relevant. The combined event rate including pneumothorax is 21 subclavian, 24 IJ, and 22 femoral. A complete non-difference between the three. Further, if you include the number of arterial punctures or placement, subclavians become even less safe, being that it is the one non-compressible site.
In addition, the failure rate for placement of a subclavian in this study is 15%, as compared to 8% and 5% IJ and femoral. Not to mention, in 540 patients the clinicians deemed the subclavian too risky, probably "randomizing" (i.e.: selecting) the highest risk patients to receive IJ and femoral lines. Finally, this study did not mandate real-time ultrasound for IJ placement nor use of chlorhexidine cleansing and dressings for central lines, both widely accepted as standard-of-care today.
This is simply an instance of a study that despite a heavily biased design intended to demonstrate subclavian superiority, is not supported by the data. This is also in the context of the the 2012 meta-analysis of all studies previously done, including two such randomized trials and over 20,000 catheters, which shows no difference in infection rates. http://www.ncbi.nlm.nih.gov/pubmed/22809915